Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stanislaw R. Burzynski, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:44 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02988726 · Antineoplaston Therapy in Treating Patients With Neurofibroma and SchwannomaBurzynski Research Institute · terminated · CNS Tumor · principal investigator
- Ph3NCT02887040 · Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem GliomaBurzynski Research Institute · not yet recruiting · Brain Stem Glioma · study chair
- Ph3NCT02864888 · Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem GliomaBurzynski Research Institute · not yet recruiting · Brain Stem Glioma · principal investigator
- Ph2NCT02742883 · A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)Burzynski Research Institute · suspended · Diffuse, Intrinsic Pontine Glioma · principal investigator
- Ph3NCT01260103 · Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway GliomaBurzynski Research Institute · withdrawn · Optic Nerve Glioma
- Ph2NCT00003530 · Antineoplaston Therapy in Treating Patients With Primary Liver CancerBurzynski Research Institute · terminated · Primary Liver Cancer · principal investigator
- Ph2NCT00003492 · Antineoplaston Therapy in Treating Patients With Stage IV Lung CancerBurzynski Research Institute · terminated · Stage IV Lung Cancer · principal investigator
- Ph2NCT00003516 · Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerBurzynski Research Institute · terminated · Prostate Cancer · principal investigator
- Ph2NCT00003460 · Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal TumorsBurzynski Research Institute · completed · Childhood CNS Primitive Neuroectodermal Tumor
- Ph2NCT00003496 · Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung CancerBurzynski Research Institute · terminated · Small Cell Lung Cancer Extensive Stage · principal investigator
- Ph2NCT00003499 · Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's LymphomaBurzynski Research Institute · completed · Low-Grade Lymphoma · principal investigator
- Ph2NCT00003521 · Antineoplaston Therapy in Treating Patients With Soft Tissue SarcomaBurzynski Research Institute · terminated · Soft Tissue Sarcoma · principal investigator
- Ph2NCT00003454 · Antineoplaston Therapy in Treating Women With Stage IV Breast CancerBurzynski Research Institute · terminated · Stage IV Breast Cancer · principal investigator
- Ph2NCT00003455 · Antineoplaston Therapy in Treating Women With Advanced Breast CancerBurzynski Research Institute · withdrawn · Stage IV Breast Cancer, Recurrent Breast Cancer · study chair
- Ph2NCT00003497 · Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerBurzynski Research Institute · terminated · Stage IV Non-small Cell Lung Cancer · principal investigator
- Ph2NCT00003470 · Antineoplaston Therapy in Treating Patients With Anaplastic AstrocytomaBurzynski Research Institute · completed · Anaplastic Astrocytoma · principal investigator
- Ph2NCT00003502 · Antineoplaston Therapy in Treating Patients With Mantle Cell LymphomaBurzynski Research Institute · withdrawn · Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma · study chair
- Ph2NCT00003459 · Antineoplaston Therapy in Treating Patients With Brain Stem GliomaBurzynski Research Institute · completed · Brain Stem Gliomas · principal investigator
- Ph2NCT00003494 · Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung CancerBurzynski Research Institute · terminated · Bronchial Alveolar; Tumor · principal investigator
- Ph2NCT00003469 · Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous SystemBurzynski Research Institute · terminated · Rhabdoid Neoplasm of CNS · principal investigator
- Ph2NCT00003479 · Antineoplaston Therapy in Treating Patients With EpendymomaBurzynski Research Institute · terminated · Ependymoma · principal investigator
- Ph2NCT00003531 · Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic CancerBurzynski Research Institute · terminated · Stage IV Pancreatic Cancer · principal investigator
- Ph2NCT00003468 · Antineoplaston Therapy in Treating Children With Low-Grade AstrocytomaBurzynski Research Institute · completed · Low Grade Astrocytomas · principal investigator
- Ph2NCT00003533 · Antineoplaston Therapy in Treating Patients With Metastatic Prostate CancerBurzynski Research Institute · terminated · Metastatic Prostate Cancer · principal investigator
- Ph2NCT00003524 · Antineoplaston Therapy in Treating Patients With Stomach CancerBurzynski Research Institute · terminated · Stomach (Gastric) Cancer · principal investigator
- Ph2NCT00003522 · Antineoplaston Therapy in Treating Patients With Cancer of the Small IntestineBurzynski Research Institute · terminated · Small Intestine Cancer · principal investigator
- Ph2NCT00003501 · Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's LymphomaBurzynski Research Institute · terminated · Non-hodgkins Lymphoma · principal investigator
- Ph2NCT00003532 · Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian CancerBurzynski Research Institute · terminated · Stage III Ovarian Cancer, Stage IV Ovarian Cancer · principal investigator
- Ph2NCT00003485 · Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon CancerBurzynski Research Institute · terminated · Colon Cancer · principal investigator
- Ph2NCT00003476 · Antineoplaston Therapy in Treating Children With Primary Malignant Brain TumorsBurzynski Research Institute · terminated · Childhood Brain Tumor · principal investigator
- Ph2NCT00003537 · Antineoplaston Therapy in Treating Adult Patients With Anaplastic AstrocytomaBurzynski Research Institute · completed · Adult Brain Tumor · principal investigator
- Ph2NCT00003514 · Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation TherapyBurzynski Research Institute · withdrawn · Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma · study chair
- Ph2NCT00003513 · Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory NeuroblastomaBurzynski Research Institute · terminated · Neuroblastoma · principal investigator
- Ph2NCT00003512 · Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's MacroglobulinemiaBurzynski Research Institute · withdrawn · Waldenstrom Macroglobulinemia · principal investigator
- Ph2NCT00003456 · Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma MultiformeBurzynski Research Institute · completed · Glioblastoma Multiforme of Brain · principal investigator
- Ph2NCT00003473 · Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed GliomasBurzynski Research Institute · completed · Mixed Gliomas · principal investigator
- Ph2NCT00003515 · Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal TumorsBurzynski Research Institute · terminated · Primitive Neuroectodermal Tumor · principal investigator
- Ph2NCT00003500 · Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's LymphomaBurzynski Research Institute · terminated · Non-hodgkins Lymphoma · principal investigator
- Ph2NCT00003491 · Antineoplaston Therapy in Treating Patients With Stage IV Lung CancerBurzynski Research Institute · terminated · Stage IV Lung Cancer · principal investigator
- Ph2NCT00003498 · Antineoplaston Therapy in Treating Patients With Non-Hodgkin's LymphomaBurzynski Research Institute · terminated · Non Hodgkin Lymphoma · principal investigator
- Ph2NCT00003536 · Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerBurzynski Research Institute · withdrawn · Stage IV Breast Cancer, Recurrent Breast Cancer · study chair
- Ph2NCT00003472 · Antineoplaston Therapy in Treating Patients With Recurrent or Refractory OligodendrogliomaBurzynski Research Institute · terminated · Oligodendroglioma, Adult · principal investigator
- Ph2NCT00003477 · Antineoplaston Therapy in Treating Children With Visual Pathway GliomaBurzynski Research Institute · completed · Visual Pathway Glioma · principal investigator
- Ph2NCT00003486 · Antineoplaston Therapy in Treating Patients With Colon CancerBurzynski Research Institute · withdrawn · Stage IV Colon Cancer, Recurrent Colon Cancer, Adenocarcinoma of the Colon · study chair
- Ph2NCT00003495 · Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung CancerBurzynski Research Institute · terminated · Stage IV Lung Cancer · principal investigator
- Ph2NCT00003517 · Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerBurzynski Research Institute · withdrawn · Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer · study chair
- Ph2NCT00003525 · Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or VulvaBurzynski Research Institute · terminated · Cervical Cancer Stage IV, Vulvar Cancer, Stage IV · principal investigator
- Ph2NCT00003453 · Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerBurzynski Research Institute · terminated · Stage IV Adrenocortical Carcinoma · principal investigator
- Ph2NCT00003452 · Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the BladderBurzynski Research Institute · terminated · Stage IV Bladder Cancer · principal investigator
- Ph2NCT00003489 · Antineoplaston Therapy in Treating Patients With Advanced Head and Neck CancerBurzynski Research Institute · terminated · Head and Neck Cancer · principal investigator
- Ph2NCT00003511 · Antineoplaston Therapy in Treating Patients With Multiple MyelomaBurzynski Research Institute · terminated · Multiple Myeloma · principal investigator
- Ph2NCT00003474 · Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma MultiformeBurzynski Research Institute · completed · Glioblastoma Multiforme of the Brain · principal investigator
- Ph2NCT00003475 · Antineoplaston Therapy in Treating Patients With Primary Malignant Brain TumorsBurzynski Research Institute · completed · Malignant Brain Tumors · principal investigator
- Ph2NCT00003471 · Antineoplaston Therapy in Treating Patients With Low-Grade AstrocytomaBurzynski Research Institute · terminated · Low-Grade Astrocytoma, Nos · principal investigator
- Ph2NCT00003509 · Antineoplaston Therapy in Treating Patients With Stage IV MelanomaBurzynski Research Institute · terminated · Stage IV Melanoma · principal investigator
- Ph2NCT00003520 · Antineoplaston Therapy in Treating Patients With Stage IV Kidney CancerBurzynski Research Institute · terminated · Stage IV Kidney Cancer · principal investigator
- Ph2NCT00003508 · Antineoplaston Therapy in Treating Patients With Advanced MesotheliomaBurzynski Research Institute · terminated · Malignant Mesothelioma · study chair
- Ph2NCT00003535 · Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade GliomaBurzynski Research Institute · terminated · High Grade Glioma · principal investigator
- Ph2NCT00003505 · Antineoplaston Therapy in Treating Patients With Primary Central Nervous System LymphomaBurzynski Research Institute · withdrawn · Primary Central Nervous System Lymphoma · study chair
- Ph2NCT00003483 · Antineoplaston Therapy in Treating Patients With MeningiomaBurzynski Research Institute · terminated · Meningioma · principal investigator
- Ph2NCT00003526 · Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary OriginBurzynski Research Institute · terminated · Unknown Primary Carcinoma · principal investigator
- Ph2NCT00003534 · Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate CancerBurzynski Research Institute · withdrawn · Stage IV Prostate Cancer · principal investigator
- Ph2NCT00003487 · Antineoplaston Therapy in Treating Patients With Cancer of the EsophagusBurzynski Research Institute · terminated · Adenocarcinoma of the Esophagus
- Ph2NCT00003457 · Antineoplaston Therapy in Treating Patients With Brain TumorsBurzynski Research Institute · completed · Refractory Brain Tumors · principal investigator
- Ph2NCT00003458 · Antineoplaston Therapy in Treating Children With Brain TumorsBurzynski Research Institute · completed · Childhood Brain Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).